Partial and full agonists of a1 adenosine receptors

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 19/16 (2006.01)

Patent

CA 2476683

Disclosed are novel compounds that are partial and full A1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, myocardial infarction and hyperlipidemia. In one aspect, the invention relates to a compound of formula I: (see formula I) or a pharmaceutically acceptable salt thereof, wherein: R1 is cyclopentyl or cyclohexyl, either of which may be optionally substituted with hydroxy or -CO2CH2CH3; R2 is hydrogen; R3 is phenyl, isoxazolyl, thiophenyl, or thiazolyl, any of which may be optionally substituted with one or more substituents selected from methyl, methoxy, fluoro, and chloro; R4 and R5 are hydrogen; T is a covalent bond or methylene; X is a covalent bond; Y is -O-, -S-, -NH-, or a covalent bond; and Z is methylene or ethylene.

L'invention porte sur de nouveaux compos~s qui sont des agonistes partiels et complets des r~cepteurs de l'ad~nosine A´1?, et qui sont utiles dans le traitement de divers ~tats pathologiques, notamment la tachycardie et le flutter auriculaire, l'angine, l'infarctus du myocarde et l'hyperlipid~mie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Partial and full agonists of a1 adenosine receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Partial and full agonists of a1 adenosine receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Partial and full agonists of a1 adenosine receptors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1436985

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.